The development of clinical interventions that significantly improve human healthspan
requires robust markers of biological age as well as thoughtful therapeutic targets. To …

Cancer patients present with abnormalities of coagulation tests, reflecting a
hypercoagulable state, often asso-ciated with a high incidence of thrombotic complications …

Purpose To assess the ability of preoperative plasma fibrinogen and D-dimer as biomarkers
to predict survival outcomes in patients with non–muscle-invasive bladder cancer (NMIBC) …

Systemic inflammation and activation of haemostasis are common in patients with lung
cancer. Both conditions support tumour growth and metastasis. Therefore, inflammatory and …

Background Post-stroke depression (PSD) is the most common psychological consequence
of stroke. Increased inflammatory markers resulting from ischemic stroke may played an …

Background: Nutritional status, systemic inflammation, and coagulation mechanism are
closely related to tumor progression. Herein, we examined the role of fibrinogen-to-albumin …

Inflammation is deeply involved in the development of most types of cancer. Many studies
focus on the interaction between immune-inflammatory mechanisms and tumorigenesis in …

Data on biomarkers of vascular injury and type 2 diabetes (T2D) risk from prospective
studies are lacking. We evaluated seven biomarkers of vascular injury in relation to T2D …

Background Fine particulate matter (PM 2.5) is a modifiable environmental risk factor with
established adverse effects on human health. However, associations between acute PM 2.5 …

This study aimed to measure the expression of SAA2 in plasma and to assess its diagnostic
efficacy as a biomarker for non-small cell lung cancer (NSCLC). The gene expression of …